"10.1371_journal.pone.0092311","plos one","2014-03-19T00:00:00Z","Patrick N Harter; Jenny Zinke; Alexander Scholz; Julia Tichy; Cornelia Zachskorn; Hans M Kvasnicka; Benjamin Goeppert; Céline Delloye-Bourgeois; Elke Hattingen; Christian Senft; Joachim P Steinbach; Karl H Plate; Patrick Mehlen; Dorothea Schulte; Michel Mittelbronn","Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany; Senckenberg Institute of Pathology, University of Frankfurt am Main, Frankfurt am Main, Germany; Institute of Pathology, University of Heidelberg, Heidelberg, Germany; Apoptosis, Cancer and Development Laboratory, Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France; Institute of Neuroradiology, University of Frankfurt am Main, Frankfurt am Main, Germany; Department of Neurosurgery, University of Frankfurt am Main, Frankfurt am Main, Germany","Conceived and designed the experiments: PNH AS HMK BG CDB EH PM DS MM. Performed the experiments: PNH JZ AS JT CZ CDB EH DS. Analyzed the data: PNH JZ AS JT EH CS JPS KHP PM DS MM. Contributed reagents/materials/analysis tools: PNH HMK BG CDB EH CS JPS KHP PM MM. Wrote the paper: PNH AS CDB PM DS MM.","The authors have read the journal’s policy and have the following conflicts: Patrick Mehlen declares to have a conflict of interest as founder and shareholder of Netris Pharma. However, this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2014","03","Patrick N Harter","PNH",15,TRUE,9,8,11,6,TRUE,TRUE,FALSE,0,NA,FALSE
